ADORA3 Gene

HGNC Family G protein-coupled receptors, Immunoglobulin superfamily domain containing
Name adenosine A3 receptor
Description This gene encodes a protein that belongs to the family of adenosine receptors, which are G-protein-coupled receptors that are involved in a variety of intracellular signaling pathways and physiological functions. The receptor encoded by this gene mediates a sustained cardioprotective function during cardiac ischemia, it is involved in the inhibition of neutrophil degranulation in neutrophil-mediated tissue injury, it has been implicated in both neuroprotective and neurodegenerative effects, and it may also mediate both cell proliferation and cell death. Alternative splicing results in multiple transcript variants. This gene shares its 5' terminal exon with some transcripts from overlapping GeneID:57413, which encodes an immunoglobulin domain-containing protein. [provided by RefSeq, Nov 2014]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nADORA3 plays a pivotal role in immune regulation and inflammation. In neutrophils, for example, extracellular ATP released at the leading edge is rapidly metabolized to adenosine, which then activates ADORA3 locally to enhance chemotactic migration. In neonatal and activated lymphoid cells, heightened ADORA3 sensitivity modulates Toll‐like receptor–mediated responses by preferentially inhibiting pro‐inflammatory TNF‑α production while sparing immunoregulatory IL‑6 synthesis. In addition, ADORA3 expressed on mast cells, monocytes and macrophages is involved in controlling tissue factor expression, matrix metalloproteinase release, and the migratory capacity of endothelial progenitor cells – all of which underscore its central function in coordinating inflammation and immune cell trafficking."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the context of cancer biology, ADORA3 exerts context‐dependent actions that include the inhibition of tumor cell proliferation through down‐regulation of NF‑κB and cyclin D1, as well as the induction of apoptosis in several malignancies such as hepatocellular carcinoma, breast, prostate and bladder cancers. In colorectal adenocarcinomas and other solid tumors, activation of ADORA3 has been shown to mediate tonic proliferative signals that can be modulated by endogenous adenosine, while its engagement may also attenuate angiogenic factor secretion in melanoma models. These findings collectively position ADORA3 as a promising therapeutic target in oncology, with its activation or blockade able to influence tumor growth, metastatic potential and the surrounding microenvironment."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nStructure–function studies have revealed critical insights into the molecular underpinnings of ADORA3 signaling. Site‐directed mutagenesis and radioligand binding experiments have identified key amino acid residues essential for ligand recognition, receptor activation and allosteric modulation, as well as demonstrated the existence of highly cooperative homodimer interactions that affect agonist dissociation kinetics. Furthermore, investigations into receptor desensitization, internalization and recycling in cellular models – alongside the discovery of novel high‐affinity ligands such as N6‑methyladenosine – have advanced our understanding of ADORA3’s dynamic signaling properties and informed the design of selective pharmacological modulators."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in immune modulation and tumor biology, ADORA3 has emerged as a promising target for therapeutic intervention. In cardiac myocytes, ADORA3 activation triggers protective signaling cascades involving RhoA and phospholipase D that mitigate ischemia‐induced injury, while genetic variants in the ADORA3 gene have been correlated with differences in infarct size. These findings, together with evidence for the analgesic potential of ADORA3 agonists, support the development of ADORA3‐targeted drugs across a spectrum of clinical indications."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "41"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Igor Feoktistov, Sergey Ryzhov, Anna E Goldstein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mast cell-mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.RES.0000061572.10929.2D"}], "href": "https://doi.org/10.1161/01.RES.0000061572.10929.2D"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12600879"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12600879"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Stefania Gessi, Katia Varani, Stefania Merighi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.65.3.711"}], "href": "https://doi.org/10.1124/mol.65.3.711"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14978250"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14978250"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yu Chen, Naoyuki Hashiguchi, Linda Yip, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypertonic saline enhances neutrophil elastase release through activation of P2 and A3 receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Cell Physiol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpcell.00216.2005"}], "href": "https://doi.org/10.1152/ajpcell.00216.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16282197"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16282197"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Ofer Levy, Melissa Coughlin, Bruce N Cronstein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.177.3.1956"}], "href": "https://doi.org/10.4049/jimmunol.177.3.1956"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16849509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16849509"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yu Chen, Ross Corriden, Yoshiaki Inoue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1132559"}], "href": "https://doi.org/10.1126/science.1132559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17170310"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17170310"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Lea Madi, Shira Cohen, Avivit Ochayin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Rheumatol (2007)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17216675"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17216675"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Emilie Velot, Benjamin Haas, Frédérique Léonard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of the adenosine-A3 receptor stimulates matrix metalloproteinase-9 secretion by macrophages."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cardiovasc Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/cvr/cvn201"}], "href": "https://doi.org/10.1093/cvr/cvn201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18653544"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18653544"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Sang-Heon Kim, Yoon-Keun Kim, Heung-Woo Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Respir Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.rmed.2008.10.008"}], "href": "https://doi.org/10.1016/j.rmed.2008.10.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19019667"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19019667"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "A Ochaion, S Bar-Yehuda, S Cohen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellimm.2009.03.020"}], "href": "https://doi.org/10.1016/j.cellimm.2009.03.020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19426966"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19426966"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Dana Baram, Ornit Dekel, Yoseph A Mekori, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Activation of mast cells by trimeric G protein Gi3; coupling to the A3 adenosine receptor directly and upon T cell contact."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0901333"}], "href": "https://doi.org/10.4049/jimmunol.0901333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20190146"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20190146"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Katia Varani, Melissa Padovan, Fabrizio Vincenzi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Res Ther (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/ar3527"}], "href": "https://doi.org/10.1186/ar3527"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22146575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22146575"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Paulina Fernandez, Casandra Jara, Valeria Aguilera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine A₂A and A₃ receptors are involved in the human endothelial progenitor cells migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cardiovasc Pharmacol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FJC.0b013e3182471d14"}], "href": "https://doi.org/10.1097/FJC.0b013e3182471d14"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22217884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22217884"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Maria Rosito, Cristina Deflorio, Cristina Limatola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCL16 orchestrates adenosine A3 receptor and MCP-1/CCL2 activity to protect neurons from excitotoxic cell death in the CNS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4046-11.2012"}], "href": "https://doi.org/10.1523/JNEUROSCI.4046-11.2012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22378888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22378888"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Lisa K Stamp, Jody Hazlett, Rebecca L Roberts, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arthritis Res Ther (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/ar3871"}], "href": "https://doi.org/10.1186/ar3871"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22682496"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22682496"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Matt Butler, Devika Sanmugalingam, Victoria J Burton, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.201242655"}], "href": "https://doi.org/10.1002/eji.201242655"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23027555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23027555"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ross Corriden, Tim Self, Kathryn Akong-Moore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine-A3 receptors in neutrophil microdomains promote the formation of bacteria-tethering cytonemes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/embor.2013.89"}], "href": "https://doi.org/10.1038/embor.2013.89"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23817552"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23817552"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yaara Gorzalczany, Eyal Akiva, Ofir Klein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2017.03.026"}], "href": "https://doi.org/10.1016/j.canlet.2017.03.026"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28342985"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28342985"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Stefania Merighi, Prisco Mirandola, Daniela Milani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Invest Dermatol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1046/j.1523-1747.2002.00111.x"}], "href": "https://doi.org/10.1046/j.1523-1747.2002.00111.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12406340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12406340"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lea Madi, Avivit Ochaion, Lea Rath-Wolfson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-03-0651"}], "href": "https://doi.org/10.1158/1078-0432.CCR-03-0651"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15240539"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15240539"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Stefania Gessi, Elena Cattabriga, Arianna Avitabile, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-1134-03"}], "href": "https://doi.org/10.1158/1078-0432.CCR-1134-03"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15355922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15355922"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Stefania Merighi, Annalisa Benini, Prisco Mirandola, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.05334"}], "href": "https://doi.org/10.1593/neo.05334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16242072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16242072"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Stefania Gessi, Stefania Merighi, Katia Varani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Physiol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcp.20994"}], "href": "https://doi.org/10.1002/jcp.20994"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17348028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17348028"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Mojtaba Panjehpour, Fatemeh Karami-Tehrani "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine modulates cell growth in the human breast cancer cells via adenosine receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/000000007783629981"}], "href": "https://doi.org/10.3727/000000007783629981"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18351132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18351132"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "S Bar-Yehuda, S M Stemmer, L Madi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2008)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18636149"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18636149"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Stefania Merighi, Carolina Simioni, Stefania Gessi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1593/neo.09768"}], "href": "https://doi.org/10.1593/neo.09768"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19794965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19794965"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Mahmoud Aghaei, Mojtaba Panjehpour, Fatemeh Karami-Tehrani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer Res Clin Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00432-011-1031-z"}], "href": "https://doi.org/10.1007/s00432-011-1031-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21830157"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21830157"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Antonella Montinaro, Raffaella Iannone, Aldo Pinto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine receptors as potential targets in melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacol Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.phrs.2013.07.002"}], "href": "https://doi.org/10.1016/j.phrs.2013.07.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23856527"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23856527"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Weiyun Wu, Yanting He, Xiao Feng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-206 is involved in the pathogenesis of ulcerative colitis via regulation of adenosine A3 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.13525"}], "href": "https://doi.org/10.18632/oncotarget.13525"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27893428"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27893428"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Hong-Li Cao, Zi-Jin Liu, Zheng Chang "}, {"type": "b", "children": [{"type": "t", "text": "Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317706915"}], "href": "https://doi.org/10.1177/1010428317706915"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28714368"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28714368"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "René Rocha, Ángelo Torres, Karina Ojeda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Adenosine A₃ Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms19041228"}], "href": "https://doi.org/10.3390/ijms19041228"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29670017"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29670017"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Zhan-Guo Gao, Aishe Chen, Dov Barak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110960200"}], "href": "https://doi.org/10.1074/jbc.M110960200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11891221"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11891221"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "M L Trincavelli, D Tuscano, M Marroni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.62.6.1373"}], "href": "https://doi.org/10.1124/mol.62.6.1373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12435805"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12435805"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Zhan-Guo Gao, Soo-Kyung Kim, Ariel S Gross, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.63.5.1021"}], "href": "https://doi.org/10.1124/mol.63.5.1021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12695530"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12695530"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Francisco Ciruela, Catarina Albergaria, Aroa Soriano, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbamem.2009.10.016"}], "href": "https://doi.org/10.1016/j.bbamem.2009.10.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19883624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19883624"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Wen-juan Wan, Dong-mei Cui, Xiao Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of adenosine receptors in human retinal pigment epithelium cells in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Chin Med J (Engl) (2011)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21542986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21542986"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Lauren T May, Lloyd J Bridge, Leigh A Stoddart, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.11-186296"}], "href": "https://doi.org/10.1096/fj.11-186296"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21715680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21715680"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Swathi V Iyer, Atul Ranjan, Harold K Elias, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms13561"}], "href": "https://doi.org/10.1038/ncomms13561"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27886186"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27886186"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Ángelo Torres, Jose Ignacio Erices, Fabiola Sanchez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "3"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " Adenosine Receptor activation under hypoxia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2019.01.004"}], "href": "https://doi.org/10.1016/j.canlet.2019.01.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30660649"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30660649"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Akiko Ogawa, Chisae Nagiri, Wataru Shihoya, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "-methyladenosine (m"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "6"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "A) is an endogenous A3 adenosine receptor ligand."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2020.12.038"}], "href": "https://doi.org/10.1016/j.molcel.2020.12.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33472058"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33472058"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Elisabetta Coppi, Federica Cherchi, Elena Lucarini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "3"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " Receptor Subtype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms22157952"}], "href": "https://doi.org/10.3390/ijms22157952"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34360719"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34360719"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Susan Mozzicato, Bhalchandra V Joshi, Kenneth A Jacobson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.03-0592fje"}], "href": "https://doi.org/10.1096/fj.03-0592fje"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14688204"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14688204"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Z Tang, M A Diamond, J-M Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Pharmacol Ther (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.clpt.6100331"}], "href": "https://doi.org/10.1038/sj.clpt.6100331"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17728764"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17728764"}]}]}]}
Synonyms A3AR
Proteins AA3R_HUMAN
NCBI Gene ID 140
API
Download Associations
Predicted Functions View ADORA3's ARCHS4 Predicted Functions.
Co-expressed Genes View ADORA3's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View ADORA3's ARCHS4 Predicted Functions.

Functional Associations

ADORA3 has 4,974 functional associations with biological entities spanning 7 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, cell line, cell type or tissue, gene, protein or microRNA) extracted from 111 datasets.

Click the + buttons to view associations for ADORA3 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by ADORA3 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of ADORA3 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of ADORA3 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of ADORA3 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of ADORA3 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of ADORA3 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of ADORA3 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of ADORA3 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of ADORA3 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of ADORA3 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with ADORA3 gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of ADORA3 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of ADORA3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of ADORA3 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of ADORA3 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing ADORA3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing ADORA3 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with ADORA3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with ADORA3 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of ADORA3 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with ADORA3 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with ADORA3 gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with ADORA3 gene/protein from the curated CTD Gene-Disease Associations dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with ADORA3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with ADORA3 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with ADORA3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with ADORA3 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for ADORA3 protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at ADORA3 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of ADORA3 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of ADORA3 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing ADORA3 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with ADORA3 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with ADORA3 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of ADORA3 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with ADORA3 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing ADORA3 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of ADORA3 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of ADORA3 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of ADORA3 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of ADORA3 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of ADORA3 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of ADORA3 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving ADORA3 gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving ADORA3 gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving ADORA3 gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing ADORA3 protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing ADORA3 protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing ADORA3 protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by ADORA3 gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by ADORA3 gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by ADORA3 gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of ADORA3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of ADORA3 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
GTEx Tissue-Specific Aging Signatures tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding ADORA3 receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations phenotypes associated with ADORA3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with ADORA3 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
GWASdb SNP-Disease Associations diseases associated with ADORA3 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset.
GWASdb SNP-Phenotype Associations phenotypes associated with ADORA3 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of ADORA3 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for ADORA3 protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of ADORA3 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of ADORA3 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of ADORA3 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with ADORA3 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of ADORA3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of ADORA3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of ADORA3 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEGG Pathways pathways involving ADORA3 protein from the KEGG Pathways dataset.
KEGG Pathways 2026 pathways involving ADORA3 protein from the KEGG Pathways 2026 dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of ADORA3 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of ADORA3 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of ADORA3 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of ADORA3 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of ADORA3 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing ADORA3 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain ADORA3 protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by ADORA3 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of ADORA3 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by ADORA3 gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of ADORA3 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
PANTHER Pathways pathways involving ADORA3 protein from the PANTHER Pathways dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for ADORA3 from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of ADORA3 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving ADORA3 protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving ADORA3 protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with ADORA3 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
Reactome Pathways 2014 pathways involving ADORA3 protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving ADORA3 protein from the Reactome Pathways 2024 dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of ADORA3 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at ADORA3 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of ADORA3 gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of ADORA3 gene from the RummaGEO Gene Perturbation Signatures dataset.
SynGO Synaptic Gene Annotations synaptic terms associated with ADORA3 gene from the SynGO Synaptic Gene Annotations dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of ADORA3 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of ADORA3 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of ADORA3 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of ADORA3 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of ADORA3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of ADORA3 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of ADORA3 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with ADORA3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with ADORA3 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving ADORA3 protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving ADORA3 protein from the WikiPathways Pathways 2024 dataset.